Stage IV Small Lymphocytic Lymphoma Terminated Phase 1 Trials for Alvocidib (DB03496)

IndicationStatusPhase
DBCOND0028635 (Stage IV Small Lymphocytic Lymphoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00377104Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTreatment
NCT01076556Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTreatment